![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/06/2924880/0/en/Generation-Bio-to-Present-at-the-Canaccord-Genuity-44th-Annual-Growth-Conference.html
https://www.globenewswire.com/news-release/2024/06/14/2898882/0/en/Generation-Bio-to-Present-at-the-2024-TD-Cowen-Genetic-Medicines-RNA-Summit.html
https://www.globenewswire.com/news-release/2024/05/13/2880873/0/en/Generation-Bio-Announces-Recent-Business-Highlights-and-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/09/2878571/0/en/Generation-Bio-Announces-the-Presentation-of-Preclinical-Data-on-iqDNA-and-ctLNP-Platforms-at-the-ASGCT-27th-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/23/2867508/0/en/Regeneration-Biomedical-Doses-First-Patient-in-a-First-in-Human-Phase-I-Clinical-Trial-of-Stem-Cell-Therapy-delivered-directly-into-the-brain-of-Patients-with-Alzheimer-s-Disease.html
https://www.globenewswire.com/news-release/2024/04/22/2867274/0/en/Generation-Bio-Announces-the-Acceptance-of-Five-Abstracts-and-an-Invited-Oral-Presentation-at-the-American-Society-of-Gene-and-Cell-Therapy-ASGCT-27th-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/03/06/2841795/0/en/Generation-Bio-Reports-Business-Highlights-and-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/27/2835831/0/en/Generation-Bio-to-Present-at-the-2024-TD-Cowen-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2023/11/29/2787596/0/en/Generation-Bio-Announces-Strategic-Reorganization-to-Extend-Cash-Runway-for-Development-of-ctLNP-and-iqDNA-Platforms.html
https://www.globenewswire.com//news-release/2023/11/09/2777877/0/en/Generation-Bio-Reports-Business-Highlights-and-Third-Quarter-2023-Financial-Results.html